Joon H. Kang

Tumor Microenvironment Research Branch
Goyang, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal Adenocarcinoma.

Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal Adenocarcinoma.

Journal: Cancer research

Published: October 05, 2025

Inhibiting Fatty Acid Oxidation Suppresses Acquired Resistance to Standard Chemotherapy in Melanoma.

Inhibiting Fatty Acid Oxidation Suppresses Acquired Resistance to Standard Chemotherapy in Melanoma.

Journal: International journal of molecular sciences

Published: September 22, 2025

Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β.

Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β.

Journal: Cell death & disease

Published: August 05, 2025

Diagnostic Biomarker Candidates Proposed Using Targeted Lipid Metabolomics Analysis of the Plasma of Patients with PDAC.

Diagnostic Biomarker Candidates Proposed Using Targeted Lipid Metabolomics Analysis of the Plasma of Patients with PDAC.

Journal: Cancers

Published: July 30, 2025

ACAA1 knockout increases the survival rate of KPC mice by activating autophagy.

ACAA1 knockout increases the survival rate of KPC mice by activating autophagy.

Journal: Molecular metabolism

Published: June 30, 2025

Loss of SLC25A20 in Pancreatic Adenocarcinoma Reversed the Tumor-Promoting Effects of a High-Fat Diet.

Loss of SLC25A20 in Pancreatic Adenocarcinoma Reversed the Tumor-Promoting Effects of a High-Fat Diet.

Journal: Theranostics

Published: April 02, 2025

Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma.

Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma.

Journal: Bioorganic chemistry

Published: November 08, 2023

Glucose Deprivation Induces Cancer Cell Death through Failure of ROS Regulation.

Glucose Deprivation Induces Cancer Cell Death through Failure of ROS Regulation.

Journal: International journal of molecular sciences

Published: July 05, 2023

Design and Synthesis of a Novel 4-aryl-N-(2-alkoxythieno [2,3-b]pyrazine-3-yl)-4-arylpiperazine-1-carboxamide DGG200064 Showed Therapeutic Effect on Colon Cancer through G2/M Arrest.

Design and Synthesis of a Novel 4-aryl-N-(2-alkoxythieno [2,3-b]pyrazine-3-yl)-4-arylpiperazine-1-carboxamide DGG200064 Showed Therapeutic Effect on Colon Cancer through G2/M Arrest.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 18, 2022

Oxoglutarate Carrier Inhibition Reduced Melanoma Growth and Invasion by Reducing ATP Production.

Oxoglutarate Carrier Inhibition Reduced Melanoma Growth and Invasion by Reducing ATP Production.

Journal: Pharmaceutics

Published: October 20, 2020

Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.

Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.

Journal: Cells

Published: August 10, 2020

ATP Production Relies on Fatty Acid Oxidation Rather than Glycolysis in Pancreatic Ductal Adenocarcinoma.

ATP Production Relies on Fatty Acid Oxidation Rather than Glycolysis in Pancreatic Ductal Adenocarcinoma.

Journal: Cancers

Published: July 14, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026